How Facebook and Twitter could be the next disruptive force in clinical trials
Heidi Ledford (Nature News)
A Bold New Strategy for Stopping the Rise of Superbugs
Ed Yong (The Atlantic)
Single-molecule magnet controversy highlights transparency problems with U.K. research integrity system
Mark Peplow (C&EN)
The Trouble With Black-6 [Mice]
Daniel Engber (Slate)
At 24, Two Entrepreneurs Took On Cancer. At 32, They’re Worth Hundreds Of Millions
Matthew Herper (Forbes)
Why Doctors Hate Their Computers
Atul Gawande (The New Yorker)
Meet the Carousing, Harmonica-Playing Texan Who Just Won a Nobel Prize for his Cancer Breakthrough
Charles Graeber (Wired)
Heidi Ledford (Nature News)
A Bold New Strategy for Stopping the Rise of Superbugs
Ed Yong (The Atlantic)
Single-molecule magnet controversy highlights transparency problems with U.K. research integrity system
Mark Peplow (C&EN)
The Trouble With Black-6 [Mice]
Daniel Engber (Slate)
At 24, Two Entrepreneurs Took On Cancer. At 32, They’re Worth Hundreds Of Millions
Matthew Herper (Forbes)
Why Doctors Hate Their Computers
Atul Gawande (The New Yorker)
Meet the Carousing, Harmonica-Playing Texan Who Just Won a Nobel Prize for his Cancer Breakthrough
Charles Graeber (Wired)
RSS Feed
